OTC Healthcare in Switzerland
Euromonitor International's OTC Healthcare in Switzerland market report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, packaging innovations, economic/lifestyle influences, distribution or pricing issues. Forecasts illustrate how the market is set to change.
Buy online to access strategic market analysis and an interactive statistical database of volume and value market sizes, company and brand shares, distribution and pricing data.
Tables: 115 | Publication date: Apr 2009
Why buy this report
- Get insight into trends in market performance
- Pinpoint growth sectors and identify factors driving change
- Identify market and brand leaders and understand the competitive environment
Product coverage
Adult mouth care; Allergy care; Analgesics; Calming and sleeping products; Child-specific OTC healthcare; Cough; cold and allergy (hay fever) remedies; Digestive remedies; Ear care; Emergency contraception; Eye care; Medicated skin care; NRT Smoking cessation aids; OTC obesity; OTC statins; OTC triptans; Vitamins and dietary supplements; Wound treatments
Executive summary
Healthy market performance experienced in 2008
The OTC healthcare market in Switzerland posted steady growth in 2008. The biggest sector was cough, cold and allergy remedies, accounting for over a quarter of OTC healthcare sales, followed by vitamins and dietary supplements, medicated skin care, analgesics and digestive remedies. Among these major sector contributors, cough, cold and allergy remedies was the strongest performer in terms of absolute value growth, while allergy care recorded the fastest growth rate.
Key market drivers in the Swiss OTC healthcare market
Growing sales of products in the Swiss OTC healthcare market were driven mainly by factors related to growing consumer interest in a healthy diet and lifestyle, rising healthcare costs driving increased interest in self-medication, an ageing Swiss population and effects associated with climate change caused by global warming. Allergy care and NRT smoking cessation aids, for example, were particularly dynamic for these reasons.
Roche Pharma leads Switzerland OTC Healthcare market
In 2008, the top two leading brand owners in the Swiss OTC healthcare market were domestic multinationals Roche Pharma (Switzerland) Ltd and Novartis Consumer Health AG. Both Roche and Novartis lead as a result of their long-standing presence on the Swiss market and their well-known and trusted brands. Also, both companies have a wide brand portfolio, being present in most OTC sectors, but also have strong brands that lead sales, such as Supradyn (Roche Pharma (Switzerland) Ltd) and Voltaren (Novartis Consumer Health AG). Nevertheless, over the review period, even with its well-known brands, Roche Pharma (Switzerland) Ltd has lost share due to increasing competition.
Share of grocery retailers increases
Grocery retailers saw their share of total OTC healthcare sales increase in 2008 due to changing consumer preferences as lifestyles become more hectic and stressful. Consumers are increasingly convenience-orientated in their shopping attitudes, benefiting products in the following sectors: cough, cold and allergy remedies; wound treatments; adult mouth care; vitamins and dietary supplements; and ear care. The most important retail channels for OTC products remained chemists/pharmacies and parapharmacies/drugstores, but they are facing difficult times as grocery retailers such as Migros and Coop increase their presence in OTC healthcare by selling more products and private label brands at lower prices.
Positive but slow constant value growth expected
The Swiss OTC healthcare market is expected to post constant value growth over the forecast period, although it will increasingly have to deal with price competition and an increasingly saturated market. The very fragmented Swiss OTC healthcare market will possibly continue to consolidate over the forecast period. It is expected that the larger players in this market will maintain growth by starting to buy out many smaller players. Also, as companies identify changing consumer preferences, a number of new product varieties are expected to enter the market. As a result of market consolidation and new product introductions, growth rates will be slightly higher than those over the review period. However, there are too many players in the OTC healthcare which means new entrants will find it difficult to generate high returns in the short to medium term.
Table of contents
OTC HEALTHCARE IN SWITZERLAND : MARKET INSIGHT
EXECUTIVE SUMMARY
Healthy market performance experienced in 2008
Key market drivers in the Swiss OTC healthcare market
Roche Pharma leads Switzerland OTC Healthcare market
Share of grocery retailers increases
Positive but slow constant value growth expected
KEY TRENDS AND DEVELOPMENTS
Emphasis on healthy diets and lifestyle behaviour
Rising healthcare cost drives more self-medication
Population is ageing and women are having fewer children
Changes in weather patterns affect allergy sufferers
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
Table 2 Life Expectancy at Birth 2003-2008
MARKET DATA
Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
Table 5 OTC Healthcare Company Shares by Value 2004-2008
Table 6 OTC Healthcare Brand Shares by Value 2005-2008
Table 7 Penetration of Private Label by Sector 2003-2008
Table 8 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
Table 9 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
Table 10 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
Table 11 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
APPENDIX
OTC Registration and Classification
Vitamins & Dietary Supplements Registration and Classification
EU Legislation
Self-medication and Preventive Medicine
Generics
Switches
DEFINITIONS
Summary 1 Research Sources
LOCAL COMPANY PROFILES - SWITZERLAND
BIOFORCE AG - OTC HEALTHCARE - SWITZERLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 2 Bioforce AG: Key Facts
Summary 3 Bioforce AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 4 Bioforce AG: Production Statistics 2008
COMPETITIVE POSITIONING
Summary 5 Bioforce AG: Competitive Position 2008
IVF HARTMANN AG - OTC HEALTHCARE - SWITZERLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 6 IVF Hartmann AG: Key Facts
Summary 7 IVF Hartmann AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 8 IVF Hartmann AG: Competitive Position 2008
SPIRIG PHARMA AG - OTC HEALTHCARE - SWITZERLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 9 Spirig Pharma AG: Key Facts
Summary 10 Spirig Pharma AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
Summary 11 Spirig Pharma AG: Production Statistics 2007
COMPETITIVE POSITIONING
Summary 12 Spirig Pharma AG: Competitive Position 2008
STREULI PHARMA AG - OTC HEALTHCARE - SWITZERLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 13 Streuli Pharma AG: Key Facts
Summary 14 Streuli Pharma AG: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 15 Streuli Pharma AG: Competitive Position 2008
VIFOR FRIBOURG SA - OTC HEALTHCARE - SWITZERLAND
STRATEGIC DIRECTION
KEY FACTS
Summary 16 Vifor Pharma: Key Facts
Summary 17 Vifor Pharma: Operational Indicators
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 18 Vifor Pharma: Competitive Position 2008
ANALGESICS IN SWITZERLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 12 Sales of Analgesics by Subsector: Value 2003-2008
Table 13 Sales of Analgesics by Subsector: % Value Growth 2003-2008
Table 14 Herbal vs Standard Topical Analgesics 2003-2008
Table 15 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 16 Analgesics Company Shares by Value 2004-2008
Table 17 Analgesics Brand Shares by Value 2005-2008
Table 18 Forecast Sales of Analgesics by Subsector: Value 2008-2013
Table 19 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN SWITZERLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 20 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2003-2008
Table 21 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2003-2008
Table 22 Sales of Decongestants by Type: Value 2003-2008
Table 23 Sales of Decongestants by Type: % Value Growth 2003-2008
Table 24 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: Value 2003-2008
Table 25 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Type: % Value Growth 2003-2008
Table 26 Herbal vs Standard Cough, Cold and Allergy (Hay Fever) Remedies 2003-2008
Table 27 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2004-2008
Table 28 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2005-2008
Table 29 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: Value 2008-2013
Table 30 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Subsector: % Value Growth 2008-2013
DIGESTIVE REMEDIES IN SWITZERLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 31 Sales of Digestive Remedies by Subsector: Value 2003-2008
Table 32 Sales of Digestive Remedies by Subsector: % Value Growth 2003-2008
Table 33 Herbal vs Standard Digestive Remedies 2003-2008
Table 34 Digestive Remedies Company Shares by Value 2004-2008
Table 35 Digestive Remedies Brand Shares by Value 2005-2008
Table 36 Forecast Sales of Digestive Remedies by Subsector: Value 2008-2013
Table 37 Forecast Sales of Digestive Remedies by Subsector: % Value Growth 2008-2013
MEDICATED SKIN CARE IN SWITZERLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Table 38 Sales of Medicated Skin Care by Subsector: Value 2003-2008
Table 39 Sales of Medicated Skin Care by Subsector: % Value Growth 2003-2008
Table 40 Herbal vs Standard Medicated Skin Care 2003-2008
Table 41 Acne Treatments by Format: % Value Breakdown 2004-2008
Table 42 Medicated Skin Care Company Shares by Value 2004-2008
Table 43 Medicated Skin Care Brand Shares by Value 2005-2008
Table 44 Acne Treatments Brand Shares by Value 2005-2008
Table 45 Hair Loss Treatments Brand Shares by Value 2005-2008
Table 46 Forecast Sales of Medicated Skin Care by Subsector: Value 2008-2013
Table 47 Forecast Sales of Medicated Skin Care by Subsector: % Value Growth 2008-2013
VITAMINS AND DIETARY SUPPLEMENTS IN SWITZERLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR DATA
Summary 19 Dietary Supplements: Brand Ranking by Positioning 2008
SECTOR DATA
Table 48 Sales of Vitamins and Dietary Supplements by Subsector: Value 2003-2008
Table 49 Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2003-2008
Table 50 Folic Acid v Other B Vitamins 2004-2008
Table 51 Dietary Supplements by Positioning 2006-2008
Table 52 Vitamins and Dietary Supplements Company Shares by Value 2004-2008
Table 53 Vitamins and Dietary Supplements Brand Shares by Value 2005-2008
Table 54 Vitamins Brand Shares by Value 2005-2008
Table 55 Dietary Supplements Brand Shares by Value 2005-2008
Table 56 Forecast Sales of Vitamins and Dietary Supplements by Subsector: Value 2008-2013
Table 57 Forecast Sales of Vitamins and Dietary Supplements by Subsector: % Value Growth 2008-2013
NRT SMOKING CESSATION AIDS IN SWITZERLAND
HEADLINES
TRENDS
COMPETITIVE LANDSCAPE
PROSPECTS
SECTOR INDICATORS
Table 58 Number of Smokers by Gender 2003-2008
SECTOR DATA
Table 59 Sales of Smoking Cessation Aids by Subsector: Value 2003-2008
Table 60 Sales of Smoking Cessation Aids by Subsector: % Value Growth 2003-2008
Table 61 NRT Gum Flavours: % Value Breakdown 2006-2008
Table 62 Smoking Cessation Aids Company Shares by Value 2004-2008
Table 63 Smoking Cessation Aids Brand Shares by Value 2005-2008
Table 64 Forecast Sales of Smoking Cessation Aids by Subsector: Value 2008-2013
Table 65 Forecast Sales of Smoking Cessation Aids by Subsector: % Value Growth 2008-2013
EYE CARE IN SWITZERLAND
TRENDS
SECTOR DATA
Table 66 Sales of Eye Care by Subsector: Value 2003-2008
Table 67 Sales of Eye Care by Subsector: % Value Growth 2003-2008
Table 68 Standard Eye Care by Type: % Value Breakdown 2007-2008
Table 69 Eye Care Company Shares by Value 2004-2008
Table 70 Eye Care Brand Shares by Value 2005-2008
Table 71 Forecast Sales of Eye Care by Subsector: Value 2008-2013
Table 72 Forecast Sales of Eye Care by Subsector: % Value Growth 2008-2013
EAR CARE IN SWITZERLAND
TRENDS
SECTOR DATA
Table 73 Sales of Ear Care: Value 2003-2008
Table 74 Sales of Ear Care: % Value Growth 2003-2008
Table 75 Ear Care Company Shares by Value 2004-2008
Table 76 Ear Care Brand Shares by Value 2005-2008
Table 77 Forecast Sales of Ear Care: Value 2008-2013
Table 78 Forecast Sales of Ear Care: % Value Growth 2008-2013
ADULT MOUTH CARE IN SWITZERLAND
TRENDS
SECTOR DATA
Table 79 Sales of Adult Mouth Care: Value 2003-2008
Table 80 Sales of Adult Mouth Care: % Value Growth 2003-2008
Table 81 Adult Mouth Care Company Shares by Value 2004-2008
Table 82 Adult Mouth Care Brand Shares by Value 2005-2008
Table 83 Forecast Sales of Adult Mouth Care: Value 2008-2013
Table 84 Forecast Sales of Adult Mouth Care: % Value Growth 2008-2013
CALMING AND SLEEPING PRODUCTS IN SWITZERLAND
TRENDS
SECTOR DATA
Table 85 Sales of Calming and Sleeping Products: Value 2003-2008
Table 86 Sales of Calming and Sleeping Products: % Value Growth 2003-2008
Table 87 Calming and Sleeping Products Company Shares by Value 2004-2008
Table 88 Calming and Sleeping Products Brand Shares by Value 2005-2008
Table 89 Forecast Sales of Calming and Sleeping Products: Value 2008-2013
Table 90 Forecast Sales of Calming and Sleeping Products: % Value Growth 2008-2013
WOUND TREATMENTS IN SWITZERLAND
TRENDS
SECTOR DATA
Table 91 Sales of Wound Treatments by Subsector: Value 2003-2008
Table 92 Sales of Wound Treatments by Subsector: % Value Growth 2003-2008
Table 93 Wound Treatments Company Shares by Value 2004-2008
Table 94 Wound Treatments Brand Shares by Value 2005-2008
Table 95 Forecast Sales of Wound Treatments by Subsector: Value 2008-2013
Table 96 Forecast Sales of Wound Treatments by Subsector: % Value Growth 2008-2013